02:29 PM, 28th Jan 2026
Press release of Shilpa Biologicals Pvt Ltd a material subsidiary of Shilpa Medicare Limited. and mAb Tree Biologicals on achieving a Major U.S. FDA Milestone as Flagship Breakthrough Biologic secures orphan drug designation for rare blood cancers.